Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.

Heinz Wiendl

Heinz Wiendl
Direktor | Univ.-Prof. Prof. h.c. Dr. med.
Department für Neurologie
Klinik für Allgemeine Neurologie | University of Münster Münster | Institut für Translationale Neurologie
Albert-Schweitzer-Campus 1, Gebäude A1
Münster, 48149, Germany

Heinz Wiendl is professor of Neurology and chair of the Department of Neurology at the University Hospital of Muenster. In addition he is dean for research and young academics of the medical faculty Muenster, representative of the academia in the University clinic’s board of directors and head of a research group working in the field of neuroimmunology. His research is dedicated to understand immune regulation and the functional interaction between the immune and the nervous system. Within this he focusses on immuneregulation in MS and autoimmune nervous system disorders, inflammatory mechanisms of neurodegenation, biomarkers and biosignatures related to MS, and immune therapy and its adverse effects.

Prof. Wiendl studied medicine in Germany, Switzerland and USA. He has been a research fellow at the Institute of Neuroanatomy at the University of Erlangen-Nuremberg and at the Max Planck Institute for Neurobiology (Martinsried). Heinz Wiendl worked as a clinical and research fellow at the Department of Neurology Tuebingen, where he was awarded as a junior group leader for neuroimmunology, received his board certification and completed his habilitation. He was appointed as a professor of neurology and head of the clinical research group for MS and neuroimmunology in Wuerzburg in 2005 and acted as a vice-chair of the Department of Neurology. In 2010 he was recruited to the University of Muenster, where he accepted the position as a director of the Department of Neurology – Inflammatory Diseases of the Nervous System and Neurooncology after turning down parallel offers. Since 1st May 2013 he is director of the Department of Neurology in Muenster.

Heinz Wiendl acted as the speaker of the national German Competence Network of MS (KKNMS) from 2009 to 2012, and as vice-speaker since then. He is member of several boards, advisory and expert committees such as the executive board of the advisory board of the German MS patient organization (DMSG), the scientific advisory committees for the International Conferences on HLA-G and the German Society for Muscular Diseases (DGM), member of the Multiple Sclerosis Therapy Consensus Group (MSTCG) and the executive board of the German Neurologists Council (BDN). In addition he is speaker of the comprehensive research center CRC TR 128 “Multiple Sclerosis” funded by the German Research Foundation (DFG) and steering committee member of the Muenster excellence cluster “Cells in Motion” (CiM). Beginning of 2013 he was appointed vice dean for research and deputy dean of the medical faculty Muenster and he is principal investigator of the cluster of excellence “Cells in Motion” (funded by the DFG and the German Council of Science and Humanities (WR)) since 1st August 2013. In 2016 Prof. Wiendl was appointed representative of the academia in the Board of directors of the University Hospital Muenster (UKM).

Furthermore Prof. Wiendl acts as reviewer of scientific journals and national as well as international funding and non-profit organizations. Recently he has been appointed member of the expert committee on neurosciences at the DFG. His scientific achievements have been recognized by the Felix Jerusalem award of the DGM (2003), the Heinrich Pette award of the German Neurological Society (DGN, 2009), and both Sobek awards for MS research of the DMSG (young scientist’s award, 2004; researcher’s award, 2015). His research and clinical activities are reflected by more than 350 publications in peer reviewed journals, multiple book chapters, the treatment guidelines for myasthenia gravis, myositis syndromes and multiple sclerosis and five edited books.

Muenster, 21.10.2016